China's Akeso BioPharma closes $150m Series D round

China's Akeso BioPharma closes $150m Series D round

04 November, 2019

Akeso Biopharma biotech Loyal Valley Capital Sino Biopharm

Printed by Unregistered user on Sun, 28 Dec 2025 09:36:49 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Matrix-backed Chinese biotech startup Genecast closes $43m Series D1 round

Venture Capital

Chinese biotech firm Ansun BioPharma secures $80m Series B financing

Read more from Greater China

Policy & Regulations

China issues draft rules to govern AI with human-like interaction

China eases IPO rules for firms developing reusable rockets